You are here: Home » Companies » News
Business Standard

Suspected hair in tablet behind Ranbaxy import alert


During a visit to a facility of leading drugmaker Ranbaxy Laboratories last year, US inspectors found that a black fibre embedded in a tablet may have been a hair from an employee's arm, according to documents seen by Reuters. That and other quality concerns led the US Food and Drug Administration (FDA) to impose an "import alert" on its Mohali plant last week, saying the factory owned by India's biggest drugmaker by sales had not ensured manufacturing quality. Ranbaxy, which is 63.5 per cent owned by Japan's Daiichi Sankyo and gets more than 40 per cent of its ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Thu, September 19 2013. 00:46 IST